These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study. Brantsch KD; Meisner C; Schönfisch B; Trilling B; Wehner-Caroli J; Röcken M; Breuninger H Lancet Oncol; 2008 Aug; 9(8):713-20. PubMed ID: 18617440 [TBL] [Abstract][Full Text] [Related]
3. Phase 1 study of erlotinib plus radiation therapy in patients with advanced cutaneous squamous cell carcinoma. Heath CH; Deep NL; Nabell L; Carroll WR; Desmond R; Clemons L; Spencer S; Magnuson JS; Rosenthal EL Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1275-81. PubMed ID: 23182701 [TBL] [Abstract][Full Text] [Related]
4. Clinical outcomes and prognostic factors associated with the response to erlotinib in non-small-cell lung cancer patients with unknown EGFR mutational status. Aydiner A; Yildiz I; Seyidova A Asian Pac J Cancer Prev; 2013; 14(5):3255-61. PubMed ID: 23803112 [TBL] [Abstract][Full Text] [Related]
5. Use of Adjuvant Radiotherapy in the Treatment of High-risk Cutaneous Squamous Cell Carcinoma With Perineural Invasion. Stevenson ML; Criscito MC; Wilken R; Doudican NA; Bain EE; Parashar B; Carucci JA JAMA Dermatol; 2020 Aug; 156(8):918-921. PubMed ID: 32609298 [TBL] [Abstract][Full Text] [Related]
7. A prospective evaluation of the clinical, histologic, and therapeutic variables associated with incidental perineural invasion in cutaneous squamous cell carcinoma. Campoli M; Brodland DG; Zitelli J J Am Acad Dermatol; 2014 Apr; 70(4):630-636. PubMed ID: 24433872 [TBL] [Abstract][Full Text] [Related]
8. Systemic progression following complete cutaneous remission under bexarotene treatment for tumor-stage mycosis fungoides. Amitay-Laish I; David M; Hodak E J Am Acad Dermatol; 2009 Aug; 61(2):361-2. PubMed ID: 19615550 [No Abstract] [Full Text] [Related]
9. Clinical outcomes in high-risk squamous cell carcinoma patients treated with Mohs micrographic surgery alone. Marrazzo G; Zitelli JA; Brodland D J Am Acad Dermatol; 2019 Mar; 80(3):633-638. PubMed ID: 30244064 [TBL] [Abstract][Full Text] [Related]
10. Trichomegaly of the eyelashes after treatment with erlotinib in non-small cell lung cancer. Carser JE; Summers YJ J Thorac Oncol; 2006 Nov; 1(9):1040-1. PubMed ID: 17409992 [No Abstract] [Full Text] [Related]
11. Head and neck cutaneous squamous cell carcinoma requiring parotidectomy: prognostic indicators and treatment selection. Sweeny L; Zimmerman T; Carroll WR; Schmalbach CE; Day KE; Rosenthal EL Otolaryngol Head Neck Surg; 2014 Apr; 150(4):610-7. PubMed ID: 24474713 [TBL] [Abstract][Full Text] [Related]
12. Four times repeated isolated limb infusion with melphalan-controlled locoregional disease in the patient with melanoma of the leg. El Halabi H; Hijaz F; Gushchin V Am Surg; 2012 Dec; 78(12):E504-5. PubMed ID: 23265100 [No Abstract] [Full Text] [Related]
13. [Prognostic influence of cutaneous involvement in malignant tumors of the oral cavity]. Tankéré F; Camproux A; Barry B; Guedon C; Depondt J; Gehanno P Ann Otolaryngol Chir Cervicofac; 2000 Mar; 117(2):85-90. PubMed ID: 10739997 [TBL] [Abstract][Full Text] [Related]
14. Defining, treating, and studying very high-risk cutaneous squamous cell carcinomas. Miller SJ Arch Dermatol; 2010 Nov; 146(11):1292-5. PubMed ID: 21079069 [No Abstract] [Full Text] [Related]
15. Time to rethink TNM staging in cutaneous SCC. Veness MJ Lancet Oncol; 2008 Aug; 9(8):702-3. PubMed ID: 18672208 [No Abstract] [Full Text] [Related]
16. Squamous cell carcinoma of the umbilicus: management of an unusual localization. Macripò G; Caliendo V; Grassi M; Lista P; Ribero S; Giacone E; Milanese E; Ciuffreda L Tumori; 2011; 97(2):236-8. PubMed ID: 21617723 [TBL] [Abstract][Full Text] [Related]